How it may work
Promotes urinary glucose excretion through SGLT2 inhibition.
CELLIVITY / ADULT ACCESS
Are you 18 or older?
CELLIVITY is available to adults only. Supplement pages are general product information; peptide records are not a sales offer and are not for human use.
Age confirmation is a declaration, not identity verification. Restricted research access still requires separate professional eligibility checks.Privacy and legal notice ↗Level D describes sparse or indirect human evidence for this exact question; read the conclusion for direction and limits.
This guide-level grade is an orientation, not a direction-of-effect label, product grade, claim or personal recommendation.Helps the kidneys remove glucose from the blood. It has important medical uses, but healthy-ageing use has not been established.
Promotes urinary glucose excretion through SGLT2 inhibition.
Strong clinical outcomes exist for selected diabetes, kidney and heart indications; healthy-longevity use is unproven.
Prescription risks include infections, dehydration and ketoacidosis.
Prescription medical context only.
Sources + indexes
Open the linked research and official records behind this guide. Early topics may begin with a research index while stronger sources are added.